📘 La nouvelle édition du cahier Orphanet « Vivre avec une maladie rare en France » est en ligne. Basée sur des données actualisées à décembre 2025, elle recense les aides et prestations disponibles pour les personnes concernées et leurs proches. ➡️www.orpha.net/pdfs/o... #MaladiesRares #Orphanet

Join us in welcoming the newest members of the EAHAD Executive Committee, including three newly appointed members and three members reappointed for an additional three-year term: 🇫🇷 Yesim Dargaud 🇲🇹 Alexander Gatt 🇮🇹 Roberta Gualtierotti 🇬🇧 Pratima Chowdary 🇳🇱 Samantha Gouw 🇮🇪 Niamh O'Connell

📢 Prochain webinaire #EuroBloodNet avec Kathleen Freson : Genetic testing for IPFD – Advantage, limitations and future perspectives of for platelet dysfunction. 📅 11 février 2026 – 17h CET 🔗 Inscription : eurobloodnet.eu/educ...

🔁Vous n'avez pas pu assister aux webconférences MHEMO de retour du congrès de l'ECTH 2025 ? Pas de panique, les replays sont disponibles ! (Re)découvrez les présentations scientifiques commentées par nos deux reporters MHEMO ! ▶️ mhemo.fr/la-formatio...

Congratulations to @melaniedaniel.bsky.social MD at CHU de Lille and at UMR1011 team 2, led by Pr @sophiesusen.bsky.social) for her great presentation at the European Congress on Thrombosis and Haemostasis : “Unbiased assessment of VWD burden and healthcare consumption using pseudonymized big data.”

Amazing presentation by @rociovacikdiaz.bsky.social at European Congress on Thrombosis and Haemostasis (ECTH) 2025: impact of LVAD implantation on circulating proteome with a focus on the early dynamic changes. Work from Team 2 led by Professor @sophiesusen.bsky.social , UMR1011

📢 3 days left to submit your abstract for EAHAD 2026! Contribute to the continuous growth of our field by showcasing your latest discoveries and insights:

Congrats to @mickaelrosa.bsky.social and Pr Antoine Rauch on winning the Bernd R. Binder publication prize at ECTH for their 2023 paper : role of ECMO-associated shear forces on GPIba shedding resulting in platelet clearance and thrombocytopenia. Team 2 Pr @sophiesusen.bsky.social, UMR1011

Wonderful presentation by @mickaelrosa.bsky.social in the Science Fast and Furious session at ECTH2025 in Prague : effect of emicizumab focusing on monocytes/macrophages using single cell and transcriptomic data. Work from team 2 led by Professor @sophiesusen.bsky.social, UMR1011.

Team 2 UMR1011 is on its way to #ISTH2025! Here are some of the results that will be presented by team @sophiesusen.bsky.social Be sure to drop by and discuss science with us! Looking forward to sharing our passion for Hemostasis with the @isth.org community!

🚀 Unlocking Potential, Empowering Minds! 🌍 Happy International Day of Women and Girls in Science! The ISTH is committed to fostering an inclusive environment that values and supports women in Science, Technology, Engineering, and Mathematics. #WomenInScience

📢 The 2025 EAHAD Research Grants cycle is now open! Apply before March 7 for a chance to advance your career in #haemophilia and allied disorders. This year, EAHAD is offering up to 6 grants, including a new category for researchers! www.eahad.org/2025-eahad-r...

2025 EAHAD Research Grants cycle now open

2025 EAHAD Research Grants cycle now open The objective of the EAHAD Research Grants is to fund and foster pre-clinical and clinical research collaborations in Europe and to support scientific project...

eahad.org

Kick off 2025 with the first ISTH webinar of the year! ▶️Topic: Anticoagulation in Chronic Kidney Disease 🗓️Date: January 29 ⏰Time: 20:00 UTC Join expert speakers as they discuss common hemostatic challenges in patients with chronic kidney disease. 🔗 Register: bit.ly/3PPjg2N @theisn.org